A novel WT1 gene mutation associated with Wilms' tumor and congenital male genitourinary malformation

Pediatric Research

Volumn 50, Issue 3, 2001, Pages 337-344

  Sakamoto, Jun ^a   Takata, Ayako ^b   Fukuzawa, Ryuji ^b   Kikuchi, Haruhito ^b   Sugiyama, Masahiko ^a   Kanamori, Yutaka ^a   Hashizume, Kohei ^a   Hata, Jun Ichi ^b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 11; CONTROLLED STUDY; EXON; GENE; GENE MUTATION; GENE WT1; HETEROZYGOSITY; HUMAN; HUMAN CELL; INTRON; KIDNEY DISEASE; MALE GENITAL SYSTEM; NEPHROBLASTOMA; POINT MUTATION; PRIORITY JOURNAL; TUMOR CELL; UROGENITAL TRACT MALFORMATION;

EID: 0034874335     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200109000-00008     Document Type: Article

References (51)

1. Genetics of Wilms' tumor
2. Childhood cancer
3. Epidemiology of Wilms tumor
4. Homozygous deletion in Wilms' tumours of a zinc-finger gene identified by chromosome jumping
5. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
6. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus
7. Transcriptional repression mediated by the WT1' Wilms tumor gene product
8. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1
9. Alternative splicing and genomic structure of the Wilms tumor gene WT1
10. A clinical overview of WT1 gene mutations
11. WT-1 is required for early kidney development
12. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour
13. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome
14. Congenital anomalies in children with Wilms' tumor: A new survey
15. Constitutional WT1 mutations in Wilms' tumor patients
16. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor
17. The genomic organization and expression of the WT1 gene
18. Fine structure analysis of the WT1 gene in sporadic Wilms tumors
19. A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen phosphorylase (PYGM) locus can be amplified by PCR and have combined informativeness of PIC 0.95
20. Comprehensive human genetic maps: Individual and sex-specific variation in recombination
21. Microsatellite polymorphisms at the D11S554 and D11S569 loci
22. PCR detection of 9 polymorphisms in the WT1 gene
23. Dinucleotide repeat polymorphism in the human aniridia (PAX6) gene
24. Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF)
25. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms
26. Parathyroid hormone gene analysis in autosomal hypoparathyroidism using an intragenic tetranucleotide (AAAT)n polymorphism
27. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH)
28. Polymerase chain reaction (PCR) for detection of Apal polymorphism at the insulin like growth factor II gene (IGF2)
29. Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus
30. Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations
31. WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences
32. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients
33. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology
34. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene
35. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database
36. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes
37. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells
38. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors
39. Maternal allele loss in Wilms' tumour
40. Constitutional and somatic deletions of two different regions of maternal chromosome 11 in Wilms tumor
41. Regional mapping of catalase and Wilms tumor - Aniridia, genitourinary abnormalities, and mental retardation triad loci to the chromosome segment 11p1305-p1306
42. Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome)
43. Genotype/phenotype correlations in Wilms' tumor
44. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations
45. Antagonism of WT1 activity by protein self-association
46. Complete and incomplete Drash syndrome: A clinicopathologic study of five cases of a dysontogenetic-neoplastic complex
47. The Denys-Drash syndrome
48. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development
49. Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour
50. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis
51. WT1 splicing alterations tumors